These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21259046)

  • 21. Effect of lercanidipine on kidney microanatomy in Cohen-Rosenthal diabetic hypertensive rats.
    Rosenthal T; Rosenmann E; Tomassoni D; Amenta F
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):145-52. PubMed ID: 17562785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
    Gemba T; Ninomiya M; Matsunaga K; Ueda M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):463-7. PubMed ID: 8474028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
    De Ciuceis C; Salvetti M; Paini A; Rossini C; Muiesan ML; Duse S; Caletti S; Coschignano MA; Semeraro F; Trapletti V; Bertacchini F; Brami V; Petelca A; Agabiti Rosei E; Rizzoni D; Agabiti Rosei C
    Intern Emerg Med; 2017 Oct; 12(7):963-974. PubMed ID: 28647890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation.
    Yamamoto E; Tamamaki N; Nakamura T; Kataoka K; Tokutomi Y; Dong YF; Fukuda M; Matsuba S; Ogawa H; Kim-Mitsuyama S
    Stroke; 2008 Nov; 39(11):3049-56. PubMed ID: 18688015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular and neuronal hypertensive brain damage: protective effect of treatment with nicardipine.
    Amenta F; Strocchi P; Sabbatini M
    J Hypertens Suppl; 1996 Oct; 14(3):S29-35. PubMed ID: 9120663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lercanidipine versus amlodipine in hypertensive patients with cerebral ischemic stroke.
    Cao TS; Huynh VM; Tran VH
    Curr Med Res Opin; 2015 Jan; 31(1):163-70. PubMed ID: 25425058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension.
    Martinez ML; Lopes LF; Coelho EB; Nobre F; Rocha JB; Gerlach RF; Tanus-Santos JE
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):117-22. PubMed ID: 16424795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of MCP-1 in the hippocampus of SHRSP with ischemia-related delayed neuronal death.
    Sakurai-Yamashita Y; Shigematsu K; Yamashita K; Niwa M
    Cell Mol Neurobiol; 2006; 26(4-6):823-31. PubMed ID: 16758320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of downregulation of L-type calcium currents to delayed neuronal death in rat hippocampus after global cerebral ischemia and reperfusion.
    Li XM; Yang JM; Hu DH; Hou FQ; Zhao M; Zhu XH; Wang Y; Li JG; Hu P; Chen L; Qin LN; Gao TM
    J Neurosci; 2007 May; 27(19):5249-59. PubMed ID: 17494711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with nicardipine protects brain in an animal model of hypertension-induced damage.
    Amenta F; Tomassoni D
    Clin Exp Hypertens; 2004 May; 26(4):351-61. PubMed ID: 15195689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a new calcium channel blocker, KB-2796, on protein synthesis of the CA1 pyramidal cell and delayed neuronal death following transient forebrain ischemia.
    Yoshidomi M; Hayashi T; Abe K; Kogure K
    J Neurochem; 1989 Nov; 53(5):1589-94. PubMed ID: 2795019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The prior occlusion of bilateral vertebral arteries during producing global cerebral ischemic damage model may play a protective role as preconditioning].
    Geng JX; Zhang M; Li WB; Guo LH; Li QJ; Xian XH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2007 Feb; 23(1):24-9. PubMed ID: 21171360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological evidence for neuroprotective action of nebracetam on ischemic neuronal injury in the hippocampus of stroke-prone spontaneously hypertensive rats.
    Nakashima MN; Kataoka Y; Yamashita K; Kohzuma M; Ichikawa M; Niwa M; Kohno Y; Taniyama K
    Jpn J Pharmacol; 1995 Jan; 67(1):91-4. PubMed ID: 7745852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
    De Ciuceis C; Flati V; Rossini C; Rufo A; Porteri E; Di Gregorio J; Petroboni B; La Boria E; Donini C; Pasini E; Agabiti Rosei E; Rizzoni D
    Blood Press; 2014 Dec; 23(6):330-8. PubMed ID: 24786779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
    Konno S; Hirooka Y; Araki S; Koga Y; Kishi T; Sunagawa K
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):555-60. PubMed ID: 19057394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nicardipine treatment on the expression of neurofilament 200 KDa immunoreactivity in the brain of spontaneously hypertensive rats.
    Sabbatini M; Mignini F; Venarucci D; Vega JA; Amenta F
    Clin Exp Hypertens; 2001; 23(1-2):127-41. PubMed ID: 11270580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbox ylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester (CV-159), on rat ischemic brain injury.
    Miyazaki H; Tanaka S; Fujii Y; Shimizu K; Nagashima K; Kamibayashi M; Uehara T; Okuma Y; Nomura Y
    Life Sci; 1999; 64(10):869-78. PubMed ID: 10096437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.